Evidence map›Paper›PMID 37489464›Full record

ArticleTomography (Ann Arbor, Mich.)2023

Visualization of Metastatic Lung Cancer with TiNIR.

Seul-Ki Mun, Hyun Bo Sim, Ji Yeon Han, Hyeongyeong Kim, Dae-Han Park, Dong-Jo Chang, Sung-Tae Yee, Young-Tae Chang, Jong-Jin Kim

Open access · goldAbstract read
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Seul-Ki MunDepartment of Biomedical Science, Sunchon National University, 255 Jungang-ro, Suncheon 57922, Republic of Korea.ORCID 0009-0006-0353-902X
Hyun Bo SimDepartment of Biomedical Science, Sunchon National University, 255 Jungang-ro, Suncheon 57922, Republic of Korea.ORCID 0009-0000-6430-9814
Ji Yeon HanDepartment of Biomedical Science, Sunchon National University, 255 Jungang-ro, Suncheon 57922, Republic of Korea.
Hyeongyeong KimDepartment of Biomedical Science, Sunchon National University, 255 Jungang-ro, Suncheon 57922, Republic of Korea.
Dae-Han ParkDepartment of Biomedical Science, Sunchon National University, 255 Jungang-ro, Suncheon 57922, Republic of Korea.
Dong-Jo ChangDepartment of Pharmacy, Sunchon National University, 255 Jungang-ro, Suncheon 57922, Republic of Korea.ORCID 0000-0002-2452-4322
Sung-Tae YeeDepartment of Pharmacy, Sunchon National University, 255 Jungang-ro, Suncheon 57922, Republic of Korea.ORCID 0000-0002-5108-8140
Young-Tae ChangSchool of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.ORCID 0000-0002-1927-3688
Jong-Jin KimDepartment of Biomedical Science, Sunchon National University, 255 Jungang-ro, Suncheon 57922, Republic of Korea.ORCID 0000-0002-1810-5383
Sunchon National University · KRPohang University of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of efficient biomarkers and probes for monitoring and treating cancer, specifically metastatic cancer, is a critical research area that can have a significant impact on both patient outcomes and drug discovery. In this context, TiNIR has been developed to detect tumor-initiating cells (TICs), with heme oxygenase 2 (HO2) as a promising therapeutic biomarker for tumor-initiating cells. In this study, TiNIR has demonstrated its effectiveness as an

Indexed as

Lung NeoplasmsQuality of LifeHumansbiomarkersheme oxygenase 2 (HO2)metastatic lung cancerprobeTiNIR

Identifiers

PMID37489464
PMCPMC10366764
OpenAlexW4381662254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.